
Spruce Biosciences, Inc.
Spruce Biosciences, Inc. (SPRB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SPRB · as of Jun 9, 2026
Key Statistics
Explore Spruce Biosciences, Inc. Data
sprb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 54.5%
The SPRB analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $191.00, representing +287.27% upside from the current price of $49.32.
Competitors & Peers
sprb competitorsStock Performance
Full HistoryAbout Spruce Biosciences, Inc.
Spruce Biosciences, Inc. founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatmen…
what is spruce biosciences, inc. · sprb stock overview · spruce biosciences, inc. company profile · who is spruce biosciences, inc. ceo · sprb NASDAQ · spruce biosciences, inc. headquarters · spruce biosciences, inc. business segments
About Stock Overview & Key Data
Spruce Biosciences, Inc. (SPRB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 9, 2020. As of the latest trading session, SPRB stock price is $49.32, with a market capitalization of $67.7M. The stock has returned +996.00% over the past 12 months and -43.38% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Spruce Biosciences, Inc. stock is Buy, with an average 12-month price target of $191.00. In fiscal year 2025, Spruce Biosciences, Inc. reported revenue of — and net income of -$39.0M. For detailed data — including Spruce Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Spruce Biosciences, Inc. (SPRB) stock price is $49.32. The stock is traded on NASDAQ under the ticker symbol SPRB. The 52-week range is $7.00 – $838.13.